Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombocytopoietin”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Early research (Phase 1)Study completedNCT01481220
What this trial is testing

Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeThrombocytopenia
Nordic MDS Group 12
Testing effectiveness (Phase 2)UnknownNCT03014102
What this trial is testing

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

Who this might be right for
ThrombocytopoietinHematopoietic Stem Cell MobilizationHematopoietic Stem Cell Transplantation
Hongnan Mo 50
Not applicableStudy completedNCT00643929
What this trial is testing

LENS - Long-term Eltrombopag Observational Study

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 164
Early research (Phase 1)Study completedNCT00358540
What this trial is testing

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 18
Not applicableWithdrawnNCT01443351
What this trial is testing

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Zealand University Hospital
Large-scale testing (Phase 3)Study completedNCT05554913
What this trial is testing

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 63
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Testing effectiveness (Phase 2)Looking for participantsNCT06693791
What this trial is testing

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 34
Large-scale testing (Phase 3)Ended earlyNCT02158936
What this trial is testing

Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Thrombocytopaenia
Novartis Pharmaceuticals 356
Testing effectiveness (Phase 2)Looking for participantsNCT06673498
What this trial is testing

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

Who this might be right for
Thrombocytopenia
Anhui Provincial Hospital 60
Large-scale testing (Phase 3)Study completedNCT00540423
What this trial is testing

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 23
Post-approval studies (Phase 4)Study completedNCT00888901
What this trial is testing

Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Ingrid Pabinger, MD 30
Post-approval studies (Phase 4)Study completedNCT02267993
What this trial is testing

Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients

Who this might be right for
Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 58
Large-scale testing (Phase 3)Study completedNCT02391272
What this trial is testing

Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 31
Testing effectiveness (Phase 2)Study completedNCT00908037
What this trial is testing

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 82
Testing effectiveness (Phase 2)UnknownNCT02857530
What this trial is testing

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Who this might be right for
Anemia, Aplastic
Tianjin Medical University General Hospital 250
Large-scale testing (Phase 3)Study completedNCT01525836
What this trial is testing

RhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University 123
Next Page